Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Emilie Viennois, Aurélien JC Pommier, Kévin Mouzat, Abdelkader Oumeddour, Fatim-Zohra El Hajjaji, Julie Dufour, Françoise Caira, David H Volle, Silvère Baron & Jean-Marc A Lobaccaro. (2011) Targeting liver X receptors in human health: deadlock or promising trail?. Expert Opinion on Therapeutic Targets 15:2, pages 219-232.
Read now
Read now
Articles from other publishers (33)
Dmitri Sviridov & Michael Bukrinsky. (2023)
Neuro‐HIV
—New insights into pathogenesis and emerging therapeutic targets
. The FASEB Journal 37:12.
Crossref
Crossref
Ramadan Ahmed Mekheimer, Mohamed Abd-Elmonem, Mohamed Abou Elsebaa, Maiiada Hassan Nazmy & Kamal Usef Sadek. (2023) Recent developments in the green synthesis of biologically relevant cinnolines and phthalazines. Physical Sciences Reviews 8:10, pages 3183-3267.
Crossref
Crossref
Shusei Yamamoto, Ikumi Sato, Moe Fujii, Mai Kakimoto, Koki Honma, Sora Kirihara, Hinako Nakayama, Taketo Fukuoka, Satoru Tamura, Minoru Ueda, Satoshi Hirohata & Shogo Watanabe. (2023) Therapeutic effect of ouabagenin, a novel liver X receptor agonist, on atherosclerosis in nonalcoholic steatohepatitis in SHRSP5/Dmcr rat model. Canadian Journal of Physiology and Pharmacology.
Crossref
Crossref
Giuseppe Lisco, Vito Angelo Giagulli, Giovanni De Pergola, Edoardo Guastamacchia, Emilio Jirillo & Vincenzo Triggiani. (2022) The Pathogenic Role of Foam Cells in Atherogenesis: Do They Represent
Novel Therapeutic Targets?. Endocrine, Metabolic & Immune Disorders - Drug Targets 22:7, pages 765-777.
Crossref
Crossref
Lin Zhao, Wangrui Lei, Chao Deng, Zhen Wu, Meng Sun, Zhenxiao Jin, Yanbin Song, Zhi Yang, Shuai Jiang, Mingzhi Shen & Yang Yang. (2020) The roles of liver X receptor α in inflammation and inflammation‐associated diseases. Journal of Cellular Physiology 236:7, pages 4807-4828.
Crossref
Crossref
Nadine Ahmed, Noreen Ahmed, Roxana Filip & John Paul Pezacki. 2021. Nuclear Receptors. Nuclear Receptors
315
348
.
Maiiada Hassan Nazmy, Ramadan Ahmed Mekheimer, Mai E. Shoman, Mohamed Abo-Elsebaa, Mohamed Abd-Elmonem & Kamal Usef Sadek. (2020) Densely functionalized cinnolines: Controlled microwave-assisted facile one-pot multi-component synthesis and in vitro anticancer activity via apoptosis induction. Bioorganic Chemistry 101, pages 103932.
Crossref
Crossref
Dmitri Sviridov, Nigora Mukhamedova, Alexander A. Makarov, Alexei Adzhubei & Michael Bukrinsky. (2020) Comorbidities of HIV infection. AIDS 34:1, pages 1-13.
Crossref
Crossref
Kamal Usef Sadek, Ramadan Ahmed Mekheimer & Mohamed Abd-Elmonem. (2019) Recent Developments in the Synthesis of Cinnoline Derivatives. Mini-Reviews in Organic Chemistry 16:6, pages 578-588.
Crossref
Crossref
Irene Zwarts, Tim van Zutphen, Janine K. Kruit, Weilin Liu, Maaike H. Oosterveer, Henkjan J. Verkade, N. Henriette Uhlenhaut & Johan W. Jonker. (2019) Identification of the fructose transporter GLUT5 (SLC2A5) as a novel target of nuclear receptor LXR. Scientific Reports 9:1.
Crossref
Crossref
Pengfei Xu, Yonggong Zhai & Jing Wang. (2018) The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis. International Journal of Molecular Sciences 19:4, pages 1260.
Crossref
Crossref
Satoru Tamura, Maiko Okada, Shigeaki Kato, Yasuharu Shinoda, Norifumi Shioda, Kohji Fukunaga, Kumiko Ui-Tei & Minoru Ueda. (2018) Ouabagenin is a naturally occurring LXR ligand without causing hepatic steatosis as a side effect. Scientific Reports 8:1.
Crossref
Crossref
Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu & Shuyi Si. (2017) Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics. Molecular Pharmacology 91:4, pages 264-276.
Crossref
Crossref
Andrew R. MendelsohnJames W. Larrick. (2016) Preclinical Reversal of Atherosclerosis by FDA-Approved Compound that Transforms Cholesterol into an Anti-Inflammatory “Prodrug”. Rejuvenation Research 19:3, pages 252-255.
Crossref
Crossref
Sebastian ZimmerAlena GrebeSiril S. BakkeNiklas BodeBente HalvorsenThomas UlasMona SkjellandDominic De NardoLarisa I. LabzinAnja KerksiekChris HempelMichael T. HenekaVictoria HawxhurstMichael L. FitzgeraldJonel TrebickaIngemar BjörkhemJan-Åke GustafssonMarit WesterterpAlan R. TallSamuel D. WrightTerje EspevikJoachim L. SchultzeGeorg NickenigDieter LütjohannEicke Latz. (2016) Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming. Science Translational Medicine 8:333.
Crossref
Crossref
Reyna K. V. Lim, Shan Yu, Bo Cheng, Sijia Li, Nam-Jung Kim, Yu Cao, Victor Chi, Ji Young Kim, Arnab K. Chatterjee, Peter G. Schultz, Matthew S. Tremblay & Stephanie A. Kazane. (2015) Targeted Delivery of LXR Agonist Using a Site-Specific Antibody–Drug Conjugate. Bioconjugate Chemistry 26:11, pages 2216-2222.
Crossref
Crossref
Takayuki Matsuda, Ayumu Okuda, Yuichiro Watanabe, Tohru Miura, Hidefumi Ozawa, Ayako Tosaka, Koichi Yamazaki, Yuki Yamaguchi, Sayaka Kurobuchi, Minoru Koura & Kimiyuki Shibuya. (2015) Design and discovery of 2-oxochromene derivatives as liver X receptor β-selective agonists. Bioorganic & Medicinal Chemistry Letters 25:6, pages 1274-1278.
Crossref
Crossref
Wenchao Zheng, Natalia Mast, Aicha Saadane & Irina A. Pikuleva. (2015) Pathways of cholesterol homeostasis in mouse retina responsive to dietary and pharmacologic treatments. Journal of Lipid Research 56:1, pages 81-97.
Crossref
Crossref
Suresh Gadde, Orli Even-Or, Nazila Kamaly, Apoorva Hasija, Philippe G. Gagnon, Krishna H. Adusumilli, Andrea Erakovic, Anoop K. Pal, Xue-Qing Zhang, Nagesh Kolishetti, Jinjun Shi, Edward A. Fisher & Omid C. Farokhzad. (2014) Development of Therapeutic Polymeric Nanoparticles for the Resolution of Inflammation. Advanced Healthcare Materials 3:9, pages 1448-1456.
Crossref
Crossref
Irina A. Pikuleva & Christine A. Curcio. (2014) Cholesterol in the retina: The best is yet to come. Progress in Retinal and Eye Research 41, pages 64-89.
Crossref
Crossref
Cheng Huang. (2014) Natural modulators of liver X receptors. Journal of Integrative Medicine 12:2, pages 76-85.
Crossref
Crossref
Elisabeth Uitz. (2014) Practical strategies for modulating foam cell formation and behavior. World Journal of Clinical Cases 2:10, pages 497.
Crossref
Crossref
Alejandro de Athayde Moncorvo Collado, Natalia Corbalán, László Homolya, Roberto Morero & Carlos Minahk. (2013) Resveratrol modulates ATPase activity of liposome‐reconstituted ABCG1. FEBS Letters 587:15, pages 2359-2363.
Crossref
Crossref
Ling Zhang, Meixiu Jiang, Yongsheng Shui, Yuanli Chen, Qixue Wang, Wenquan Hu, Xingzhe Ma, Xiaoju Li, Xin Liu, Xingyue Cao, Mengyang Liu, Yajun Duan & Jihong Han. (2013) DNA topoisomerase II inhibitors induce macrophage ABCA1 expression and cholesterol efflux—An LXR-dependent mechanism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1831:6, pages 1134-1145.
Crossref
Crossref
Thomas P. Burris, Laura A. Solt, Yongjun Wang, Christine Crumbley, Subhashis Banerjee, Kristine Griffett, Thomas Lundasen, Travis Hughes & Douglas J. Kojetin. (2013) Nuclear Receptors and Their Selective Pharmacologic Modulators. Pharmacological Reviews 65:2, pages 710-778.
Crossref
Crossref
J Laurencikiene & M Rydén. (2012) Liver X receptors and fat cell metabolism. International Journal of Obesity 36:12, pages 1494-1502.
Crossref
Crossref
Julie Dufour, Emilie Viennois, Hugues De Boussac, Silvère Baron & Jean-Marc Lobaccaro. (2012) Oxysterol receptors, AKT and prostate cancer. Current Opinion in Pharmacology 12:6, pages 724-728.
Crossref
Crossref
XianYun Jiao, David J. Kopecky, Ben Fisher, Derek E. Piper, Marc Labelle, Sharon McKendry, Martin Harrison, Stuart Jones, Juan Jaen, Andrew K. Shiau, Patrick Escaron, Jean Danao, Anne Chai, Peter Coward & Frank Kayser. (2012) Discovery and optimization of a series of liver X receptor antagonists. Bioorganic & Medicinal Chemistry Letters 22:18, pages 5966-5970.
Crossref
Crossref
Emilie Viennois, Kevin Mouzat, Julie Dufour, Laurent Morel, Jean-Marc Lobaccaro & Silvère Baron. (2012) Selective liver X receptor modulators (SLiMs): What use in human health?. Molecular and Cellular Endocrinology 351:2, pages 129-141.
Crossref
Crossref
Chiara Giannarelli, Giovanni Cimmino, Thomas M. Connolly, Borja Ibanez, Josè M. Garcia Ruiz, Matilde Alique, M. Urooj Zafar, Valentin Fuster, Giora Feuerstein & Juan J. Badimon. (2012) Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis. European Heart Journal 33:2, pages 264-273.
Crossref
Crossref
Hendrian Sukardi, Xiaoyan Zhang, Eei Yin Lui, Choong Yong Ung, Sinnakaruppan Mathavan, Zhiyuan Gong & Siew Hong Lam. (2012) Liver X receptor agonist T0901317 induced liver perturbation in zebrafish: Histological, gene set enrichment and expression analyses. Biochimica et Biophysica Acta (BBA) - General Subjects 1820:1, pages 33-43.
Crossref
Crossref
Chunhua Zhu, Dongmei Di, Xiaoying Zhang, Guanghua Luo, Zongchun Wang, Jiang Wei, Yuanping Shi, Maria Berggren-Söderlund, Peter Nilsson-Ehle & Ning Xu. (2011) TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells. Lipids in Health and Disease 10:1.
Crossref
Crossref
M. Shafaati, M. Olin, A. Båvner, H. Pettersson, B. Rozell, S. Meaney, P. Parini & I. Björkhem. (2011) Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo. Journal of Internal Medicine 270:4, pages 377-387.
Crossref
Crossref